ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Respiratory Tract Diseases
Chronic Obstructive Pulmonary Disease
Conjunctivitis
Dust Mite Allergy

Asthma trials near Berlin, BE, DEU:

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...

Active, not recruiting
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

Phase 2

Upstream Bio

Berlin, Germany and 156 other locations

is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...

Active, not recruiting
Asthma
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Berlin, Germany and 282 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Enrolling
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Berlin, Germany and 77 other locations

This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated w...

Enrolling
Eosinophilic Asthma
Combination Product: Placebo for Benralizumab
Combination Product: benralizumab

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 140 other locations

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...

Enrolling
Asthma
Drug: dupilumab
Drug: Matching Placebo

Phase 4

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Berlin, Germany and 82 other locations

and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Atuliflapon

Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 266 other locations

levels compared with placebo in participants with moderate-to-severe asthma.Study participation will last approximately 65 weeks, including ...

Enrolling
Asthma
Drug: Brenipatide
Drug: Placebo

Phase 2

Lilly
Lilly

Berlin, Germany and 117 other locations

This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.

Active, not recruiting
Asthma
COPD (Chronic Obstructive Pulmonary Disease)
Biological: GB-0895 (SC)
Drug: Placebo (SC)

Phase 1

Generate Biomedicines

Berlin, Germany and 12 other locations

administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...

Active, not recruiting
Asthma
Device: Inhaler
Drug: AZD8630

Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 195 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Enrolling
Asthma
Drug: Short-Acting Beta Agonists (SABA)
Drug: Fluticasone/salmeterol

Phase 2

Sanofi
Sanofi

Berlin, Germany and 231 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems